{"nct_id":"NCT04152863","title":"Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)","status":"TERMINATED","status_verified_date":"2024-07","start_date":"2020-06-05","start_date_type":"ACTUAL","primary_completion_date":"2023-07-12","primary_completion_date_type":"ACTUAL","completion_date":"2023-07-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}